Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is a highly aggressive cancer with poor prognosis. The lack of effective targeted therapies for TNBC remains a profound clinical challenge. Fusion transcripts play critical roles in carcinogenesis and serve as valuable diagnostic and therapeutic targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng-Yuan, Huang, Man, Wang, Chao-Yi, Tang, Xiao-Ying, Wang, Jian-Gen, Yang, Yong-De, Xiong, Xin, Gao, Chao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239224/
https://www.ncbi.nlm.nih.gov/pubmed/34211850
http://dx.doi.org/10.3389/fonc.2021.682021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239224/
https://www.ncbi.nlm.nih.gov/pubmed/34211850
http://dx.doi.org/10.3389/fonc.2021.682021

Ejemplares similares